Back

Should we continue to routinely revascularize patients during valve surgery in optimal medical therapy era?

2 September 2019 (08:30 - 12:30)
Organised by:
Congress Presentation Part of: Poster Session 4 - ACS: revascularisation, cancer, valve, atrial fibrillation et al. Revascularisation ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Joao Pedro Dias Ferreira Reis

Hospital de Santa Marta, Lisbon (Portugal)

10 More presentations in this session

Presentation thumbnail
Doctor A. Tinggaard (Aarhus, DK)
Abstract Slides
Presentation thumbnail
Professor G. Pedrazzini (Lugano, CH)
Abstract
Presentation thumbnail
Assistant Professor D. Kanda (Kagoshima, JP)
Abstract
Presentation thumbnail
Doctor R. Attar (Malmo, SE)
Abstract Slides
Presentation thumbnail
Doctor T. Carvalho Mendonca (Lisbon, PT)
Abstract

Access the full session

Session thumbnail
Poster Session 4 - ACS: revascularisation, cancer, valve, atrial fibrillation et al.

The Event

Event poster

ESC Congress 2019

2 September 2019 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Impact of revascularization of complex coronary disease in patients with chronic coronary disease: are we being too invasive?
29 June 2021
thumbnail
Congress Presentation
The results of the cardiac resynchronization therapy in heart failure patients with postcardiac valve surgery.
29 June 2021
thumbnail
Webinar
Perioperative management of patients with specific diseases undergoing non-cardiac surgery. ESC 2022 Clinical Practice Guidelines - Webinar Series
24 October 2022
thumbnail
Congress Presentation
Rational and design of EACVI-MMVD study: an international registry on multimodality imaging for mixed and multiple valvular heart disease
11 December 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources